Difference between revisions of "Part:BBa K4137007:Design"
Andreahuang (Talk | contribs) |
|||
(3 intermediate revisions by 2 users not shown) | |||
Line 10: | Line 10: | ||
pLac promoter is chosen for constitutive expression of ccdB. | pLac promoter is chosen for constitutive expression of ccdB. | ||
The fusion of ccdB and myc epitope tag allows the isolation of ccdB from the ccdB-ccdA complex upon purification for easy identification of individual concentrations. | The fusion of ccdB and myc epitope tag allows the isolation of ccdB from the ccdB-ccdA complex upon purification for easy identification of individual concentrations. | ||
+ | |||
Latest revision as of 07:51, 10 October 2022
pLac+RBS+CcdB-Myc+B1006
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI site found at 271
Design Notes
RBS is used to enhance ccdB synthesis. pLac promoter is chosen for constitutive expression of ccdB. The fusion of ccdB and myc epitope tag allows the isolation of ccdB from the ccdB-ccdA complex upon purification for easy identification of individual concentrations.
Source
https://www.ncbi.nlm.nih.gov/nuccore/U51588.1 https://sci-hub.hkvisa.net/10.1016/0022-2836(85)90070-1 https://2018.igem.org/Team:Pasteur_Paris/Kill